Effective January 20, 2017, Rule 64B13-18.002, F.A.C. adds Xiidra (Lifitegrast Ophthalmic Solution) 5% to the formulary and allows Florida Optometrists to prescribe the medication to their patients.
More Latest News
January 10, 2018
The Annual Long Range Planning meeting has been rescheduled for Monday, April 23, 2018. Please click here for more information. Continue reading
November 3, 2017
Chronic Disease Prevention: A Public Health Perspective. Please click for details on how to register for this webinar. Continue reading